Funded Tech Companies

Hexagon Bio

Researching who provided funding to Hexagon Bio? Nextech, The Column Group and 8VC joined the equity holders in this biopharmaceutical company.

Company Overview

Contact Information

Company Background Information

Overview

Hexagon Bio's mission to identify medicines encoded in the global metagenome, and bring them to patients. While nature's molecules have proven to be a rich source of potent medicines, their translation has been laborious and hindered by the lack of mechanistic understanding of the intended target.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

2/13/2023

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Maureen Hillenmeyer

        

Founder

Colin Harvey

        

Founder

Brian Naughton

        

Founder

Yi Tang

        

Vice President

James Li

        

VP - Bus. Development

Sofia Touami

        

VP - Engineering

Andrew Aymeloglu

        

Company Investors

• Nextech
• The Column Group (David Goeddel)
• 8VC (Alex Kolicich)
• Two Sigma Ventures (Dusan Perovic)
• Canada Pension Plan Investment Board
• SoftBank Vision Fund
• Nextech Invest (Jakob Loven)
• Casdin Capital

Browse more funded tech companies:

Hexagon AB | Hexarad

Share this article

About Our VC Deals Database

This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary